Medicare beneficiaries face much higher drug costs as plans quickly shift to co-insurance
Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, according to new research ...
Feb 18, 2025
0
1
